TriangleNCT01772719 · OUTCOME
Duration of Response
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- Year 1 follow up visits occur monthly
What was measured
Response will be accessed by one of the study investigators at each monthly follow up visit during year one.
Analysis population: Study Terminated, zero total participants analyzed
Groups in this outcome
Simvastatin and Zoledronic Acid
Simvastatin and zoledronic acid: 1. Simvastatin 80 mg PO daily starting two days before starting chemotherapy and stopping two days after chemotherapy. 2. Zoledronic acid 4 mg IV over 15 minutes on day 1 and then monthly.
| Group | Source count |
|---|---|
| Simvastatin and Zoledronic Acid | 0 |
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denoms
- counts
- group Id
- OG000
- value
- 0
- units
- Participants
- description
- Response will be accessed by one of the study investigators at each monthly follow up visit during year one.
- groups
- description
- Simvastatin and zoledronic acid: 1. Simvastatin 80 mg PO daily starting two days before starting chemotherapy and stopping two days after chemotherapy. 2. Zoledronic acid 4 mg IV over 15 minutes on day 1 and then monthly.
- id
- OG000
- title
- Simvastatin and Zoledronic Acid
- population Description
- Study Terminated, zero total participants analyzed
- reporting Status
- POSTED
- time Frame
- Year 1 follow up visits occur monthly
- title
- Duration of Response
- type
- SECONDARY
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice